Biotechnology (6) | Repurchase Agreements (6)
Browse by Company
Recent Contracts
-
Share Repurchase Agreement, dated as of March 31, 2021, by and between Agios Pharmaceuticals, Inc. and Bristol-Myers Squibb Company
(AGIOS PHARMACEUTICALS INC, Filed With SEC on April 2, 2021)
-
Form of Warrant Repurchase Agreement
(Savara Inc, Filed With SEC on March 11, 2021)
-
Stock Repurchase Agreement, dated as of May 25, 2020, by and between Regeneron Pharmaceuticals, Inc. and Sanofi
(Regeneron Pharmaceuticals, Filed With SEC on May 29, 2020)
-
Common Stock Repurchase Agreement
(Inmune Bio, Inc., Filed With SEC on January 27, 2020)
-
Fixed Dollar Accelerated Share Repurchase Transaction, dated May 7, 2019, by and between Anika Therapeutics, Inc. and Morgan Stanley & Co. LLC
(Anika Therapeutics, Filed With SEC on July 26, 2019)
-
Stock Repurchase Agreement between the Registrant and Robert Connelly, effective as of May 31, 2018
(Axcella Health Inc., Filed With SEC on April 12, 2019)
